These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25821228)

  • 41. In HIV-infected patients, some differential alterations of CD4 and CD8 T cell homeostasis may not be restored by ≥ 7 years of highly active antiretroviral therapy, in spite of good CD4 T cell repopulation.
    Bordoni V; Agrati C; Rinaldi A; Viola D; De Simone G; Gioia C; Martini F
    J Antimicrob Chemother; 2012 Jul; 67(7):1802-4. PubMed ID: 22461310
    [No Abstract]   [Full Text] [Related]  

  • 42. Contribution of CD4+, CD8+CD28+, and CD8+CD28- T cells to CD3+ lymphocyte homeostasis during the natural course of HIV-1 infection.
    Caruso A; Licenziati S; Canaris AD; Cantalamessa A; Fiorentini S; Ausenda S; Ricotta D; Dima F; Malacarne F; Balsari A; Turano A
    J Clin Invest; 1998 Jan; 101(1):137-44. PubMed ID: 9421475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells.
    Gehri R; Hahn S; Rothen M; Steuerwald M; Nuesch R; Erb P
    AIDS; 1996 Jan; 10(1):9-16. PubMed ID: 8924258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults.
    Boer MC; Prins C; van Meijgaarden KE; van Dissel JT; Ottenhoff TH; Joosten SA
    Clin Vaccine Immunol; 2015 Jul; 22(7):778-88. PubMed ID: 25947145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.
    Echeverría A; Moro-García MA; Asensi V; Cartón JA; López-Larrea C; Alonso-Arias R
    J Leukoc Biol; 2015 Sep; 98(3):373-84. PubMed ID: 26034206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
    Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
    Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.
    Lind A; Sommerfelt M; Holmberg JO; Baksaas I; Sørensen B; Kvale D
    Scand J Infect Dis; 2012 Aug; 44(8):566-72. PubMed ID: 22339485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Battling the enemy on many fronts: inside the science of HIV vaccine development.
    Talley A; Chang S
    Body Posit; 2004; 17(4):8-12. PubMed ID: 15929208
    [No Abstract]   [Full Text] [Related]  

  • 49. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis.
    Mittrücker HW; Steinhoff U; Köhler A; Krause M; Lazar D; Mex P; Miekley D; Kaufmann SH
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12434-9. PubMed ID: 17640915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1.
    Kolber MA
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1002-7. PubMed ID: 15539497
    [No Abstract]   [Full Text] [Related]  

  • 51. HIV infection: where have all the T cells gone?
    Rowland-Jones S
    Lancet; 1999 Jul; 354(9172):5-7. PubMed ID: 10406356
    [No Abstract]   [Full Text] [Related]  

  • 52. Frequency of provirus-bearing CD4+ cells in HIV type 1 infection correlates with extent of in vitro apoptosis of CD8+ but not of CD4+ cells.
    Carbonari M; Cibati M; Pesce AM; Sbarigia D; Grossi P; D'Offizi G; Luzi G; Fiorilli M
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):789-94. PubMed ID: 7546905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The rapid and slow progression of HIV infection].
    Soriano V; Martín R; del Romero J
    Rev Clin Esp; 1995 Oct; 195(10):708-14. PubMed ID: 8532928
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro selection of HIV and CMV specific T-lymphocytes.
    Li Pira G; Bottone L; Ivaldi F; Ricciardi A; Barbano G; Manca F
    J Biol Regul Homeost Agents; 2004; 18(2):183-6. PubMed ID: 15471225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reply to Mandorfer et al.
    Hull MW; Rollet K; Klein MB;
    Clin Infect Dis; 2013 Mar; 56(6):905-6. PubMed ID: 23243174
    [No Abstract]   [Full Text] [Related]  

  • 57. Blocking of HIV entry through CD44-hyaluronic acid interactions.
    Turville S
    Immunol Cell Biol; 2014 Oct; 92(9):735-6. PubMed ID: 25155464
    [No Abstract]   [Full Text] [Related]  

  • 58. How to "spot" a real killer.
    Snyder JE; Mosmann TR
    Trends Immunol; 2003 May; 24(5):231; author reply 231-2. PubMed ID: 12738412
    [No Abstract]   [Full Text] [Related]  

  • 59. Gene-based passive antibody protection from HIV.
    Liu MA
    Nat Biotechnol; 2012 Feb; 30(2):156-7. PubMed ID: 22318034
    [No Abstract]   [Full Text] [Related]  

  • 60. Response to Bandera et al.
    Wilson EM; Hullsiek KH; Sereti I; Baker JV
    J Infect Dis; 2015 Sep; 212(5):841-2. PubMed ID: 25791115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.